Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers

Martin J. Scurr, Wioleta M. Zelek, George Lippiatt, Michelle Somerville, Stephanie E. A. Burnell, Lorenzo Capitani, Kate Davies, Helen Lawton, Thomas Tozer, Tara Rees, Kerry Roberts, Mererid Evans, Amanda Jackson, Charlotte Young, Lucy Fairclough, Mark Wills, Andrew D. Westwell, B. Paul Morgan, Awen Gallimore, Andrew Godkin
doi: https://doi.org/10.1101/2021.06.02.21258218

Data Availability

The data that support the findings of this study are available on request from the corresponding author.

Back to top
Posted June 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers
Martin J. Scurr, Wioleta M. Zelek, George Lippiatt, Michelle Somerville, Stephanie E. A. Burnell, Lorenzo Capitani, Kate Davies, Helen Lawton, Thomas Tozer, Tara Rees, Kerry Roberts, Mererid Evans, Amanda Jackson, Charlotte Young, Lucy Fairclough, Mark Wills, Andrew D. Westwell, B. Paul Morgan, Awen Gallimore, Andrew Godkin
medRxiv 2021.06.02.21258218; doi: https://doi.org/10.1101/2021.06.02.21258218
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area